Press release
The Umbilical Cord Blood Banking Market to Be Driven By Neurotechnology
The Umbilical Cord Blood Banking Market is expected to grow on a healthy note in the subsequent decade. With value-based care picking up, close to 15% of the entire population is under its umbrella as of now. Programs like "Online Bachelor's Degree in General Studies with a Concentration in Healthcare" is being floated, which could aid professionals to lead in the value-based care strategies. In other words, the future belongs to professionals bringing conventional skills in communication, care, and leadership with new-fangled skills in analytics and technology. So, "being value-based" would hold value in the healthcare vertical in the future.Persistence Market Research (PMR), a market intelligence and research firm, has recently published a market study on the global umbilical cord blood (UCB) banking market. According to the report, the worldwide UCB banking market stood at US$12.7 bn in 2013. Analysts at PMR anticipate the market to exhibit a moderate CAGR of 6.10% during the period from 2014 to 2020 and gain a market value of US$19.3 bn by the end of the forecast period.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/3043
In 2014, analysts valued this market at US$13.5 bn and it stood at US$10.9 bn in 2010.
Some of the major players operating in the UCB banking market:
Cord Blood Registry Systems, Inc.
Cordlife Group Limited.
Cord Blood America, Inc.
NeoStem Inc.
Cryo-Cell International, Inc.
ViaCord.
Esperite NV.
Smart Cells International Ltd.
China Cord Blood Corporation.
The research report, titled "Global Market Study on UCB Banking: Asia-Pacific to Witness Highest Growth by 2020", states that the rising incidence of chronic diseases, disorders, and injuries are the key driving factors fuelling the growth of the worldwide market for UCB banking. In addition to this, various initiatives by several government associations, intended to raise awareness regarding the importance as well as benefits of UCB banking, are also propelling the global UCB banking market to a great extent.
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/3043
Contrarily, the stringent regulations and procedures pertaining to license and accreditation are hampering the growth of the UCB banking market in the global arena. Apart from this, the high fee associated with banking of cord blood in private UCB banks is also projected to limit the global market for UCB banking over the forecast period, the report states.
The report analyzes the global UCB banking market on two fronts: therapeutic application of UCB and storage option. By therapeutic application of UCB, the market is segmented into leukemia, lymphoma, metabolic/storage diseases, bone marrow failure syndromes, and immune deficiencies. On the basis of storage option, the market is classified into public UCB banks and private UCB bank.
According to the research report, Europe, North America, Asia Pacific, and the Rest of the World are the major regional markets for UCB banking. Among these, North America has acquired the leading position. The rising prevalence of chronic diseases also extensively drives the UCB banking market in this region.
The UCB banking market in Europe is also driven by the growing prevalence of diseases and disorders. The growing awareness regarding therapeutic applications of cord is also significantly contributing to the development of the UCB banking market in Europe.
The Asia Pacific market for UCB banking is also registering a steady growth. The increasing number of accidents and rising prevalence of fatal disorders are propelling the demand for cord blood banking in the region, notes the market study.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/3043
Access Related Reports-
Healthcare Information Systems Market: https://www.persistencemarketresearch.com/market-research/healthcare-information-systems-market.asp
UK Private Healthcare Market: https://www.persistencemarketresearch.com/market-research/uk-private-healthcare-market.asp
Contact Us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com
About Us:
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Umbilical Cord Blood Banking Market to Be Driven By Neurotechnology here
News-ID: 2553775 • Views: …
More Releases from Persistence Market Research
North America Household Washer and Dryer Market Set to Reach US$ 22.2 Bn by 2032 …
The North America household washer and dryer market is poised for steady growth, supported by rising demand for smart home appliances, changing lifestyle patterns, and technological enhancements in laundry equipment. The market is projected to reach US$ 17.3 billion in 2025, and with a CAGR of 3.5% from 2025 to 2032, it is expected to climb to US$ 22.2 billion by 2032.
➤ Download Your Free Sample & Explore Key Insights:…
Indoor Plants Market to Grow at 5.4% CAGR Through 2032 as Demand for Green Inter …
The global indoor plants market is poised for sustained expansion over the next several years. According to Persistence Market Research, the market is projected to grow from US$ 22.6 billion in 2025 to US$ 32.7 billion by 2032, reflecting a CAGR of 5.4% during the forecast period. This upward trajectory underscores the increasing consumer shift toward wellness-driven living, biophilic interiors, and nature-connected home environments.
➤ Download Your Free Sample & Explore…
UV Disinfection Equipment Market Poised for Strong 16.3% CAGR Growth Through 203 …
The global UV disinfection equipment market is poised for remarkable expansion over the next decade. Industry estimates indicate that the market will be valued at US$ 17.0 billion in 2025 and is projected to surge to US$ 48.9 billion by 2032, registering a powerful CAGR of 16.3% between 2025 and 2032. This accelerated growth reflects heightened global focus on safety, hygiene, water quality, and chemical-free disinfection methods across both residential…
Surfing Apparel and Accessories Market Booms at 5.5% CAGR Through 2031, Reports …
The global surfing apparel and accessories market is set for steady expansion over the next several years. According to industry estimates, the market is anticipated to rise from US$ 9.5 billion in 2024 to US$ 14.1 billion by 2031, reflecting a healthy CAGR of 5.5% during the forecast period. This upward trajectory highlights the increasing global appeal of surfing as both a sport and a lifestyle.
➤ Download Your Free Sample…
More Releases for UCB
Epilepsy Market Expected to Gain Momentum Through 2034, According to DelveInsigh …
The Key Epilepsy Companies in the market include - Aquestive Therapeutics, Atnahs Pharma (Pharmanovia), Jazz Pharmaceuticals, SK Biopharmaceutical, Angelini Pharma/Ono Pharmaceutical, Novartis, Xenon Pharmaceuticals, Takeda, Ovid Therapeutics, Biohaven Pharmaceuticals/Knopp Biosciences, and others.
DelveInsight's "Epilepsy Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Epilepsy, historical and forecasted epidemiology as well as the Epilepsy market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom…
Epilepsy Market Dynamics Indicate Upward Trajectory Through 2034, Reports DelveI …
The Key Epilepsy Companies in the market include - Aquestive Therapeutics, Atnahs Pharma (Pharmanovia), Jazz Pharmaceuticals, SK Biopharmaceutical, Angelini Pharma/Ono Pharmaceutical, Novartis, Xenon Pharmaceuticals, Takeda, Ovid Therapeutics, Biohaven Pharmaceuticals/Knopp Biosciences, and others.
DelveInsight's "Epilepsy Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Epilepsy, historical and forecasted epidemiology as well as the Epilepsy market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom…
Fibromyalgia Market to Exhibit Rapid Growth Rate During the Forecast Period (202 …
DelveInsight's "Fibromyalgia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Fibromyalgia, historical and forecasted epidemiology as well as the Fibromyalgia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Fibromyalgia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Fibromyalgia Market Forecast
https://www.delveinsight.com/sample-request/fibromyalgia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Fibromyalgia…
Anticonvulsant Market - Functional Survey 2025 | GlaxoSmithKline Inc., UCB Group
Anticonvulsant Market for Fibromyalgia: Snapshot
Anticonvulsants are pharmacological agents from a diverse group that are used for the treatment of epileptic seizures. Anticonvulsants are increasingly in demand on account of their use for the treatment of bipolar disorders. They are also used for the treatment of borderline personality disorder. Anticonvulsants act as stabilizers of mood and helps in the treatment of neuropathic pain. They suppress the rapid, excessive firing of neurons…
Epilepsy Drugs Market 2017- UCB, EISAI, Pfizer
Epilepsy Drugs Market is likely to reach nearly USD 5.5 Billion by the year end of 2021.
Market growth can be attributed to factors such as rising incidence of neurological disorders, growing disease awareness, introduction of novel antiepileptic drugs (AEDs), strong government support and initiatives. Moreover, increasing R&D investment and launch of extended-release formulations are further expected to fuel the market growth. However, high cost of patented drugs, concerns over decreasing…
Global Stem Cell UCB Market Research Report 2016
Global Stem Cell UCB Industry 2016 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2016-2020.
The market intelligence publication delves into the condition of the global Stem Cell UCB market. An in-depth examination of the existing market state, past progress, and forthcoming prospects of the global Stem Cell UCB market has been presented in the research report. The research publication also reports…
